Vir Biotechnology
+$0.30 (+0.81%) As of 4:06 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.
About VIR
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.
CEO
George A. Scangos
Employees
327
Headquarters
San Francisco, California
Founded
2016
VIR Key Statistics
Market Cap
6.01B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
703.10K
High Today
$37.74
Low Today
$36.67
Open Price
$36.90
Volume
280.75K
52 Week High
$141.01
52 Week Low
$25.31
Analyst Ratings
75%
of 8 ratings
Buy
75%
Hold
12.5%
Sell
12.5%
VIR Earnings
-$1.32
-$0.88
-$0.44
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, After Hours